Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 5
2003 3
2004 2
2005 10
2006 4
2007 3
2008 4
2009 14
2010 8
2011 3
2012 9
2013 20
2014 14
2015 15
2016 26
2017 22
2018 23
2019 21
2020 38
2021 35
2022 34
2023 33
2024 9

Text availability

Article attribute

Article type

Publication date

Search Results

332 results

Results by year

Filters applied: . Clear all
Page 1
Identification of a set of genes potentially responsible for resistance to ferroptosis in lung adenocarcinoma cancer stem cells.
Ascenzi F, Esposito A, Bruschini S, Salvati V, De Vitis C, De Arcangelis V, Ricci G, Catizione A, di Martino S, Buglioni S, Bassi M, Venuta F, De Nicola F, Massacci A, Grassucci I, Pallocca M, Ricci A, Fanciulli M, Ciliberto G, Mancini R. Ascenzi F, et al. Among authors: ciliberto g. Cell Death Dis. 2024 Apr 29;15(4):303. doi: 10.1038/s41419-024-06667-w. Cell Death Dis. 2024. PMID: 38684666 Free PMC article.
Molecular Tumor Boards: On the evolution of species.
Giacomini P, Ciliberto G. Giacomini P, et al. Among authors: ciliberto g. Eur J Cancer. 2024 Apr;201:113910. doi: 10.1016/j.ejca.2024.113910. Epub 2024 Feb 13. Eur J Cancer. 2024. PMID: 38382152 No abstract available.
Dynamics of humoral and cellular response to three doses of anti-SARS-CoV-2 BNT162b2 vaccine in patients with hematological malignancies and older subjects.
Laquintana V, Mottini C, Marchesi F, Marcozzi B, Terrenato I, Sperandio E, de Latouliere L, Carrieri F, Pimpinelli F, Pontone M, Pellini R, Campo F, Conti L, Accetta C, Mandoj C, Petrone F, Di Bella O, Vujovic B, Morrone A, Compagnone M, Principato E, Pinto E, Papa E, Falcucci P, La Malfa A, Pallocca M, De Marco F, Piaggio G, Ciliberto G, Mengarelli A, di Martino S. Laquintana V, et al. Among authors: ciliberto g. Front Immunol. 2024 Jan 26;14:1221587. doi: 10.3389/fimmu.2023.1221587. eCollection 2023. Front Immunol. 2024. PMID: 38343436 Free PMC article.
Isolation and Characterization of Neutralizing Monoclonal Antibodies from a Large Panel of Murine Antibodies against RBD of the SARS-CoV-2 Spike Protein.
D'Acunto E, Muzi A, Marchese S, Donnici L, Chiarini V, Bucci F, Pavoni E, Ferrara FF, Cappelletti M, Arriga R, Serrao SM, Peluzzi V, Principato E, Compagnone M, Pinto E, Luberto L, Stoppoloni D, Lahm A, Groß R, Seidel A, Wettstein L, Münch J, Goodhead A, Parisot J, De Francesco R, Ciliberto G, Marra E, Aurisicchio L, Roscilli G. D'Acunto E, et al. Among authors: ciliberto g. Antibodies (Basel). 2024 Jan 5;13(1):5. doi: 10.3390/antib13010005. Antibodies (Basel). 2024. PMID: 38247569 Free PMC article.
A federated learning system for precision oncology in Europe: DigiONE.
Mahon P, Chatzitheofilou I, Dekker A, Fernández X, Hall G, Helland A, Traverso A, Van Marcke C, Vehreschild J, Ciliberto G, Tonon G. Mahon P, et al. Among authors: ciliberto g. Nat Med. 2024 Feb;30(2):334-337. doi: 10.1038/s41591-023-02715-8. Nat Med. 2024. PMID: 38195748 No abstract available.
Comprehensive genomic profiling on metastatic Melanoma: results from a network screening from 7 Italian Cancer Centres.
Pallocca M, Molineris I, Berrino E, Marcozzi B, Betti M, Levati L, D'Atri S, Menin C, Madonna G, Ghiorzo P, Bulgarelli J, Ferraresi V, Venesio T, Rodolfo M, Rivoltini L, Lanfrancone L, Ascierto PA, Mazzarella L, Pelicci PG, De Maria R, Ciliberto G, Medico E, Russo G. Pallocca M, et al. Among authors: ciliberto g. J Transl Med. 2024 Jan 6;22(1):29. doi: 10.1186/s12967-023-04776-2. J Transl Med. 2024. PMID: 38184610 Free PMC article.
Efficacy and safety of chlorpromazine as an adjuvant therapy for glioblastoma in patients with unmethylated MGMT gene promoter: RACTAC, a phase II multicenter trial.
Pace A, Lombardi G, Villani V, Benincasa D, Abbruzzese C, Cestonaro I, Corrà M, Padovan M, Cerretti G, Caccese M, Silvani A, Gaviani P, Giannarelli D, Ciliberto G, Paggi MG. Pace A, et al. Among authors: ciliberto g. Front Oncol. 2023 Dec 14;13:1320710. doi: 10.3389/fonc.2023.1320710. eCollection 2023. Front Oncol. 2023. PMID: 38162492 Free PMC article.
332 results